COMMUNIQUÉS West-GlobeNewswire

Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
20/05/2026
REDWOOD CITY, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new advances in RNA [...]
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
20/05/2026
TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA; OTCQB: MDXXF) (“ PharmAla ” or the “ Company ”), a global leader in the research, development, and manufacturing of novel MDXX-class [...]
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate [...]
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive [...]
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
20/05/2026
- Surgical Implant – Next Generation contract makes Symvess more easily accessible to 170 VA hospitals – - SAC awards require intensive product and value analysis vetting by a surgical committee and streamline the [...]
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
20/05/2026
MALVERN, Pa., May 20, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
20/05/2026
Secondary analysis from the Phase 3 MAESTRO-NASH and MAESTRO-NAFLD-1 trials examines improvements in lipid profiles for Lp(a), LDL-C and ApoB with Rezdiffra ® (resmetirom) Analysis of two-year data in patients with [...]
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
20/05/2026
Transaction Positions JUNS at the Forefront of Next-Generation MDMA-Based Therapeutics Following President Trump's April 18, 2026, Executive Order Accelerating Psychedelic Medicine JUPITER, FL, May 20, 2026 (GLOBE [...]
Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity
20/05/2026
Gifts to both organizations reflect Aeroflow Urology’s continuous commitment to community partnerships that directly support underserved families ASHEVILLE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- Aeroflow Urology , a [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
20/05/2026
BOSTON, May 20, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that [...]
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
20/05/2026
IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); Immunovant will [...]
Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer
20/05/2026
Backed by the Canadian Cancer Society and Weston Family Foundation, the LUNA-2 microbiome capsule research study will be the largest of its kind in Canada LONDON, Ontario, May 20, 2026 (GLOBE NEWSWIRE) -- For nearly [...]
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
20/05/2026
Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in [...]
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
20/05/2026
Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company [...]
Avricore Health Announces $1.25 Million Financing
20/05/2026
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price [...]
CorVel Announces Revenues and Earnings
20/05/2026
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $ [...]
Disclosure of voting rights at AGM in Vistin Pharma ASA
20/05/2026
Oslo, Norway, 20 May 2026 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 20th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total [...]
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
20/05/2026
SHENZHEN, China, May 20, 2026 (GLOBE NEWSWIRE) -- Winner Medical has officially broken ground on its new manufacturing base in Hai Ha Industrial Park, Quang Ha Commune, Quang Ninh Province, Vietnam. With a total [...]
Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon
20/05/2026
Financée par la Société canadienne du cancer et la Fondation de la famille Weston, l’étude de recherche LUNA-2 sur les capsules de microbiome sera la plus vaste du genre au Canada LONDON, Ontario, 20 mai 2026 (GLOBE [...]

Pages